• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性恶性肿瘤中的微小RNA

MicroRNAs in Female Malignancies.

作者信息

Liolios Themis, Kastora Stavroula Lila, Colombo Giorgia

机构信息

Hellenic Republic National and Kapodistrian, University of Athens, Faculty of Biology, Athens, Greece.

University of Aberdeen, School of Medicine and Dentistry, Aberdeen, UK.

出版信息

Cancer Inform. 2019 Feb 13;18:1176935119828746. doi: 10.1177/1176935119828746. eCollection 2019.

DOI:10.1177/1176935119828746
PMID:30792572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6376555/
Abstract

MicroRNAs (miRNAs) are endogenous 22-nucleotide RNAs that can play a fundamental regulatory role in the gene expression of various organisms. Current research suggests that miRNAs can assume pivotal roles in carcinogenesis. In this article, through bioinformatics mining and computational analysis, we determine a single miRNA commonly involved in the development of breast, cervical, endometrial, ovarian, and vulvar cancer, whereas we underline the existence of 7 more miRNAs common in all examined malignancies with the exception of vulvar cancer. Furthermore, we identify their target genes and encoded biological functions. We also analyze common biological processes on which all of the identified miRNAs act and we suggest a potential mechanism of action. In addition, we analyze exclusive miRNAs among the examined malignancies and bioinformatically explore their functionality. Collectively, our data can be employed in in vitro assays as a stepping stone in the identification of a universal machinery that is derailed in female malignancies, whereas exclusive miRNAs may be employed as putative targets for future chemotherapeutic agents or cancer-specific biomarkers.

摘要

微小RNA(miRNA)是一种内源性22个核苷酸的RNA,可在各种生物体的基因表达中发挥重要的调节作用。目前的研究表明,miRNA在癌症发生过程中可能发挥关键作用。在本文中,通过生物信息学挖掘和计算分析,我们确定了一种在乳腺癌、宫颈癌、子宫内膜癌、卵巢癌和外阴癌发展过程中共同涉及的单一miRNA,同时我们强调除外阴癌外,在所有检测的恶性肿瘤中还存在另外7种常见的miRNA。此外,我们确定了它们的靶基因和编码的生物学功能。我们还分析了所有已鉴定的miRNA所作用的共同生物学过程,并提出了一种潜在的作用机制。此外,我们分析了所检测的恶性肿瘤中的特异性miRNA,并通过生物信息学方法探索了它们的功能。总的来说,我们的数据可用于体外试验,作为识别在女性恶性肿瘤中失调的通用机制的垫脚石,而特异性miRNA可作为未来化疗药物或癌症特异性生物标志物的假定靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/68efeb1d565e/10.1177_1176935119828746-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/8afd8ca44526/10.1177_1176935119828746-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/76afe04cefaf/10.1177_1176935119828746-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/f0faee1da6bf/10.1177_1176935119828746-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/458ca30db97a/10.1177_1176935119828746-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/68efeb1d565e/10.1177_1176935119828746-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/8afd8ca44526/10.1177_1176935119828746-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/76afe04cefaf/10.1177_1176935119828746-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/f0faee1da6bf/10.1177_1176935119828746-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/458ca30db97a/10.1177_1176935119828746-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b37/6376555/68efeb1d565e/10.1177_1176935119828746-fig5.jpg

相似文献

1
MicroRNAs in Female Malignancies.女性恶性肿瘤中的微小RNA
Cancer Inform. 2019 Feb 13;18:1176935119828746. doi: 10.1177/1176935119828746. eCollection 2019.
2
Role of microRNAs in gynecological pathology.微小 RNA 在妇科病理学中的作用。
Curr Med Chem. 2012;19(15):2406-13. doi: 10.2174/092986712800269362.
3
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.基于系统发育分析和各种人乳头瘤病毒亚型的结构进化,对病毒 microRNA 进行全基因组发现。
Brief Bioinform. 2018 Nov 27;19(6):1102-1114. doi: 10.1093/bib/bbx046.
4
Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.一种新型微小RNA:人CDH4基因内的hsa-miR-B43的生物信息学预测及实验验证,其在乳腺癌中具有潜在的转移相关功能。
J Cell Biochem. 2020 Feb;121(2):1307-1316. doi: 10.1002/jcb.29367. Epub 2019 Sep 6.
5
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.微小RNA表达与基因调控驱动PyMT小鼠乳腺癌的进展和转移。
Breast Cancer Res. 2016 Jul 22;18(1):75. doi: 10.1186/s13058-016-0735-z.
6
Identification of miRNAs during mouse postnatal ovarian development and superovulation.小鼠出生后卵巢发育和超排卵过程中miRNA的鉴定。
J Ovarian Res. 2015 Jul 8;8:44. doi: 10.1186/s13048-015-0170-2.
7
MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.微小RNA:子宫内膜癌发生的潜在调节因子
Microrna. 2015;4(1):18-25. doi: 10.2174/2211536604666150710094418.
8
MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?微小 RNA 在子宫平滑肌瘤的发生发展及病理生物学中的作用:证据是否支持未来的临床干预策略?
Hum Reprod Update. 2014 Sep-Oct;20(5):670-87. doi: 10.1093/humupd/dmu017. Epub 2014 Apr 4.
9
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
10
Role of components of microRNA machinery in carcinogenesis.微小RNA机制的组成部分在致癌过程中的作用。
Exp Oncol. 2018 Mar;40(1):2-9.

引用本文的文献

1
miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study.miR-21 和 miR-145 作为宫颈癌患者放疗反应的预后生物标志物:一项初步研究。
Int J Mol Sci. 2024 Sep 30;25(19):10545. doi: 10.3390/ijms251910545.
2
The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions.性激素和 microRNAs 在子宫内膜癌中的相互作用:当前的认识和未来的方向。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1166948. doi: 10.3389/fendo.2023.1166948. eCollection 2023.
3
Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB.

本文引用的文献

1
SLC27A2 regulates miR-411 to affect chemo-resistance in ovarian cancer.SLC27A2 通过调节 miR-411 影响卵巢癌的化疗耐药性。
Neoplasma. 2018 Nov 15;65(6):915-924. doi: 10.4149/neo_2018_180122N48. Epub 2018 Sep 4.
2
Cancer of the vulva.外阴癌。
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:4-13. doi: 10.1002/ijgo.12609.
3
Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.宫颈癌的潜在生物标志物和治疗靶点:从网络医学视角下转录组学数据的荟萃分析中获得的见解。
通过由癌症标志ERBB驱动的机器学习方法发现女性特异性癌症潜在的常见miRNA特征
Biomedicines. 2022 Jun 2;10(6):1306. doi: 10.3390/biomedicines10061306.
4
Circulating Hsa-miR-431-5p as Potential Biomarker for Squamous Cell Vulvar Carcinoma and Its Premalignant Lesions.循环中的人源微小RNA-431-5p作为外阴鳞状细胞癌及其癌前病变的潜在生物标志物
Diagnostics (Basel). 2021 Sep 17;11(9):1706. doi: 10.3390/diagnostics11091706.
5
Breast Cancer and the Other Non-Coding RNAs.乳腺癌与其他非编码 RNA
Int J Mol Sci. 2021 Mar 23;22(6):3280. doi: 10.3390/ijms22063280.
6
MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies.微小RNA:解读妇科恶性肿瘤的有力工具。
Front Oncol. 2020 Oct 23;10:591181. doi: 10.3389/fonc.2020.591181. eCollection 2020.
7
miR-519 regulates the proliferation of breast cancer cells via targeting human antigen R.微小RNA-519通过靶向人类抗原R调控乳腺癌细胞的增殖。
Oncol Lett. 2020 Feb;19(2):1567-1576. doi: 10.3892/ol.2019.11230. Epub 2019 Dec 20.
8
The Emerging Role of Major Regulatory RNAs in Cancer Control.主要调控RNA在癌症控制中的新兴作用
Front Oncol. 2019 Sep 24;9:920. doi: 10.3389/fonc.2019.00920. eCollection 2019.
PLoS One. 2018 Jul 18;13(7):e0200717. doi: 10.1371/journal.pone.0200717. eCollection 2018.
4
Correlation between miR-222 and uterine cancer and its prognostic value.miR-222与子宫癌的相关性及其预后价值。
Oncol Lett. 2018 Aug;16(2):1722-1726. doi: 10.3892/ol.2018.8815. Epub 2018 May 25.
5
MicroRNAs as markers of progression in cervical cancer: a systematic review.微小 RNA 作为宫颈癌进展的标志物:系统评价。
BMC Cancer. 2018 Jun 27;18(1):696. doi: 10.1186/s12885-018-4590-4.
6
miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.miR-3147 通过抑制 Smad4 在外阴鳞癌中发挥癌基因作用。
Mol Med Rep. 2018 May;17(5):6397-6404. doi: 10.3892/mmr.2018.8697. Epub 2018 Mar 7.
7
Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.miR-597 低表达与乳腺癌的肿瘤分期和不良预后相关。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):456-460. doi: 10.26355/eurrev_201801_14195.
8
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.微小RNA-101通过靶向性别决定区Y框蛋白2抑制乳腺癌细胞的生长、增殖和迁移并诱导其凋亡。
Cell Physiol Biochem. 2017;43(2):717-732. doi: 10.1159/000481445. Epub 2017 Sep 27.
9
MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.miR-9、miR-21 和 miR-155 作为 HPV 阳性和阴性宫颈癌的潜在生物标志物。
BMC Cancer. 2017 Sep 21;17(1):658. doi: 10.1186/s12885-017-3642-5.
10
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.循环 microRNAs 在乳腺癌中的作用:新型诊断和预后生物标志物。
Cell Death Dis. 2017 Sep 7;8(9):e3045. doi: 10.1038/cddis.2017.440.